Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06477172 · ClinicalTrials.gov registry record
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
A clinical trial of Post Procedural Erythema, sponsored by Acorn Biolabs.
- Recruiting
- Registry status
- 500
- Enrollment target
- 20
- Study locations
NCT06477172 is a study of Post Procedural Erythema that is actively recruiting participants, run by Acorn Biolabs. The registered enrollment target is 500 participants. The trial reports 20 study locations across 8 states.
The verdict
NCT06477172, a study of Post Procedural Erythema, is actively recruiting participants, sponsored by Acorn Biolabs.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 20
- Study locations
Study Summary
Non-interventional, multi-site, prospective, open-label, observational, real-world study of autologous hair follicle secretome use.
Conditions Studied
Study Locations (20)
California
- Arash Moradzadeh MD - Beverly Hills
- Glenn Vallecillos, MD Inc - Beverly Hills
- Behr Laser & Skin Care Center - Fresno
- Aesthetics By Dr. Lee - Granite Bay
- Carlo Honrado, MD, FACS - Los Angeles
- Marcus Medical - Manhattan Beach
- N2 Aesthetics - Manhattan Beach
- Marina Plastic Surgery - Marina del Rey
- M Beauty by Tess - San Diego
- Modern Aesthetics - Walnut Creek
- Dr. Christie - West Hollywood
- Ziering Medical - West Hollywood
Florida
- Bauman Medical - Boca Raton
- Mirror Plastic Surgery - St. Petersburg
Alabama
- Skin Wellness Dermatology - Birmingham
Arizona
- BelleSante - Scottsdale
Colorado
- BEAUTY by BUFORD - Lone Tree
Illinois
- Hive Aesthetic LLC - Chicago
Indiana
- Chernoff Cosmetic Surgery - Indianapolis
Michigan
- ICON Antiaging & Aesthetics - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-09-09 |
| Est. Completion | 2027-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06477172
The ClinicalTrials.gov registry entry for NCT06477172 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Acorn Biolabs, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post Procedural Erythema appearing as the primary indexed condition, and to 0 interventions.
NCT06477172 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT06477172 about?
NCT06477172 is a clinical study titled "Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures". Non-interventional, multi-site, prospective, open-label, observational, real-world study of autologous hair follicle secretome use.
What is the current status of trial NCT06477172?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-09-09. Estimated completion is 2027-02.
What conditions does trial NCT06477172 study?
This clinical trial studies the following conditions: Post Procedural Erythema.
Who is sponsoring clinical trial NCT06477172?
This trial is sponsored by Acorn Biolabs, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06477172 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.